HMGB1 and neoplasm: Currently, HMGB1 Ab, HMGB1 antagonist, HMGB1 inhibitor, and nucleic acid technology inhibit expression, secretion, and signal transduction of HMGB1 in tumor cells, which plays a key role in anti-inflammation therapy [40–43].